April 2018

U.S. ex rel. Ruckh v. CMC II LLC et al. (“Ruckh”) was a closely followed False Claims Act case, because a Florida Federal Court…

In mid-March 2018, five New York City doctors were arrested and charged with accepting bribes and kickbacks from Insys…

On Wednesday, April 4, 2018, Food and Drug Administration (FDA) Commissioner Scott Gottlieb spoke at the National Rx Drug Abuse…

In a closely watched matter culminating years of litigation, Medtronic on December 12, 2017, entered into a $12 Million…

On March 22, 2018, the State of Washington officially enacted the first statewide drug take-back program in the country.…

As Life Science Compliance Update enters its fourth year of publication, it is a great pleasure to announce that Nicodemo…

Last week, the House Energy and Commerce Subcommittee on Health held a two-day hearing entitled “Combating the Opioid Crisis:…

For analyzing so-called “Big Data” sets, data analytics is an invaluable set of tools and techniques. Now the HHS OIG plans to…

Here we are…barely finished with the first quarter of 2018, and the United States Food and Drug Administration (FDA) Office of…

Health Affairs and the National Pharmaceutical Council held a briefing focused on efforts to increase value and monitor costs on…